Thomas B. Hakes

Second-line platinum therapy in patients with ovarian cancer previously treated with cisplatin.

Maurie Markman, Robert Rothman, Thomas B. Hakes et al. · Journal of Clinical Oncology · 1991 · 851 citations

Surgical Oncology, Overall Response Rates, Cisplatin Programs +12

Phase I trial of intraperitoneal taxol: a Gynecoloic Oncology Group study.

Maurie Markman, Eric K. Rowinsky, Thomas B. Hakes et al. · Journal of Clinical Oncology · 1992 · 313 citations

Responses to second-line cisplatin-based intraperitoneal therapy in ovarian cancer: influence of a prior response to intravenous cisplatin.

Maurie Markman, Bonnie Reichman, Thomas B. Hakes et al. · Journal of Clinical Oncology · 1991 · 190 citations

Surgical Oncology, Intravenous Cisplatin, Ip Cisplatin Initiation +14

Randomized prospective trial of 5 versus 10 cycles of cyclophosphamide, doxorubicin, and cisplatin in advanced ovarian carcinoma

Thomas B. Hakes, Eva Chalas, W.J. Hoskins et al. · Gynecologic Oncology · 1992 · 166 citations

Medicine, Metronomic Therapy, Gynecology +8

Ifosfamide and mesna in previously treated advanced epithelial ovarian cancer: activity in platinum-resistant disease.

M Markman, Thomas B. Hakes, Bonnie Reichman et al. · Journal of Clinical Oncology · 1992 · 135 citations